logo
School of Biomedical Sciences
   
   
  
 

Image of Lopa Leach

Lopa Leach

Associate Professor of Vascular Biology, Faculty of Medicine & Health Sciences

Contact

  • workRoom E176a The University of Nottingham Medical School
    Queen's Medical Centre
    Nottingham
    NG7 2UH
    UK
  • work0115 82 30175
  • fax0115 82 30142

Biography

please see above.

Teaching Summary

Human Anatomy, Reproductive System and Renal Physiology

Research Summary

Interests

  • Vascular dysfunction in Diabetes, specifically pregnancies complicated by diabetes (Type 1, Type 2 and GDM).
  • Molecular mechanisms underlying physiological vasculogenesis and angiogenesis.
  • Endothelial barrier function.
  • Role of VE-cadherin and beta-catenin in pathological angiogenesis.
  • Modelling neo-vascularisation in age-related macular degeneration.
  • Mathematical modelling of blood flow in the placenta

Techniques

  • Ex vivo perfusion of human placental vascular beds.
  • In vitro modelling of endothelial angiogenesis.
  • In vitro modelling of barrier function.
  • Confocal imaging of junctional proteins.
  • Tissue culture of primary and immortalised human endothelial, endothelial progenitor and epithelial cells.
  • Immunocytochemistry, Immunoblotting, electron microscopy, transfection of cells.

Projects

  • In vitro development of a model for age related macula degeneration, (The Wellcome Trust).
  • Modelling Flow and Growth in the placenta (Medical Research Council).
  • Identification of transcription factors and cognate signal transducing pathways activated during stages of angiogenesis (Association of International Cancer Research).
  • Modelling diabetic angiogenesis (Anatomical Society of Great Briatain and Ireland).
  • Vascular dysfunction in the human diabetic placenta: molecular mechanisms behind angiogenesis versus permeability changes. (The Anatomical Society of great Britain and Ireland)
  • Mathematical modelling of placental flow (Marie Curie, EU)
  • VEGF and angiopoietins in vascular permeability
  • Local Collaborators
  • Professor Oliver Jensen
  • Mr A Foss (Ophthalmology) Mr G Bugg (Academic Obstetrics) Professor Penny Gowland (Physics)

UK Collaborators

  • Dr Zoe Brooks, University of Sheffield (BHF grant: angiopoietins in sepsis)
  • Dr David Bates, University of Bristol (splice variant of VEGF-A in diabetic placenta)

International Collaborators

  • Dr Gernot Desoye, University of Graz, Austria.
  • Dr K Juuti-Uustilo, University of Tampere, Finland

Recent Publications

Future Research

Endothelial barrier function, junctional adhesion molecules, human placenta, angiogenesis, diabetes mellitus.

Physiological and pathological angiogenesis, adhesion molecules and signalling.

We research into how blood vessels grow (angiogenesis) and maintain a selective barrier (permeability) in health and how it may go wrong in disease. These functions are extremely important in the human placenta, which protects and feeds the growing baby throughout pregnancy. Thus our main study is that into understanding blood vessel function in the human placenta in normal and diabetic pregnancies. The role of the mother's nutrition during pregnancy may also have an effect on the placenta and is a recent inclusion. To aid these studies we also have endothelial cell models in culture (2-D and 3-D) which lets us look at the role of individual key growth factors and into how we may control or revert pathological processes. Our second interest is into diseases of the eye which includes diabetes and age-related macula degeneration. We have a successful human model which mimics the arrangements of the blood vessels in the eye. Again, increased angiogenesis and leakiness can lead to blindness and we are investigating ways to prevent this. Impairment in vascular function, specifically increased angiogenesis and vascular leakage, is a major complication of diseases such as diabetes, cancer and hypertension. The adhesion molecules which hold the lining cells i.e. the endothelial cells together play a role in both these functions. Our group uses ex vivo human perfusion models and in vitro cell cultures to understand the signalling and regulation of these molecules and how they may go wrong, specially in diabetes. Our major interest is the functioning of blood vessels in the human placenta, in normal and diabetic pregnancies. The placenta is vital for fetal nutrition, development, growth and well-being throughout gestation and impaired placental function causes fetal morbidity and mortality. Moreover, in-utero disturbances may lead to fetal programming and increased risk of cardiovascular diseases and diabetes in adulthood. We wish to develop therapeutic strategies to prevent the vascular complications we have shown to exist in the placenta in pregnancies complicated by diabetes. We have a near-physiological, extra-corporeal placental perfusion system which allows us to look at the effect of key factors on trans-placental transport, whilst in vitro models allow more long term effects on angiogenic parameters to be studied. We have a near-physiological, extra-corporeal placental perfusion system which allows us to look at the effect of key factors on trans-placental transport. This system allows monitoring of maternal and fetal blood flow and pressure and lends itself to studies of directional transport. We have expertise into growth of primary endothelial cells in 2-D or 3-D culture systems to study barrier properties and angiogenesis. We have a trilayer model of the outer retinal barrier which allows studies into drug transport as well as hypoxia-mediated neo-vascularisation. Immunocytochemistry, confocal microscopy and real time imaging, as well as standard molecular biology which include immunoblotting are routinely used in our laboratory. We also have expertise of immuno-electron methods and standard transmission electron microscopy. The growth factors of specific interest to us include vascular endothelial growth factor and angiopoietin-1. We have knowledge of the behaviour of junctional adhesion molecules (occludin, VE-cadherin and beta-catenin) in regulating paracellular permeability, endothelial survival and angiogenesis.

School of Biomedical Sciences

University of Nottingham
Medical School
Queen's Medical Centre
Nottingham, NG7 2UH

telephone: +44 (0) 115 823 0141
email: enquiries